Veradigm Inc. (MDRX)
| Market Cap | 825.89M +0.1% |
| Revenue (ttm) | 594.41M -60.9% |
| Net Income | -291.54M |
| EPS | -2.70 |
| Shares Out | 170.29M |
| PE Ratio | n/a |
| Forward PE | 20.59 |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 3,597 |
| Open | 4.650 |
| Previous Close | 4.850 |
| Day's Range | 4.650 - 4.800 |
| 52-Week Range | 3.250 - 6.000 |
| Beta | 0.56 |
| Analysts | Buy |
| Price Target | 6.50 (+36.84%) |
| Earnings Date | Sep 11, 2026 |
About Veradigm
Veradigm Inc., a healthcare technology company, provides information technology solutions to healthcare providers, payers, and biopharma markets in the United States and internationally. The company offers solutions to healthcare providers, comprising practice management software, AI patient scheduling software, and electronic statements and payments, and payerpath clearinghouse; revenue cycle services and coding services; electronic health records solutions, which include eprescribe with EPCS, EHR software, veradigm EHR, and practice fusion EH... [Read more]
Financial Performance
Financial StatementsAnalyst Summary
According to 2 analysts, the average rating for MDRX stock is "Buy." The 12-month stock price target is $6.50, which is an increase of 36.84% from the latest price.
News
Veradigm to Participate in Two Upcoming Investor Conferences
CHICAGO--(BUSINESS WIRE)--Veradigm® (OTCMKTS: MDRX), a leading provider of clinical and revenue cycle solutions for independent practices, announced today that management will be participating in the ...
Veradigm Transcript: Investor update
Achieved timely filing of 2023 and 2024 10-Ks, setting the stage for 2025 and 2026 filings and a potential relisting. Revenue and profitability remain flat, but operational improvements, AI adoption, and cost actions are expected to drive margin expansion and growth in 2026.
Veradigm Files 2023 and 2024 Form 10-K
CHICAGO--(BUSINESS WIRE)--Veradigm® (OTCMKTS: MDRX), a leading provider of clinical and revenue cycle solutions for independent practices, announced today the filing of its comprehensive Annual Report...
Veradigm to Release Business Update May 26th and Host Investor Call May 27th
CHICAGO--(BUSINESS WIRE)--Veradigm® (OTCMKTS: MDRX), a leading provider of clinical and revenue cycle solutions for independent practices, announced today that management plans to provide a business u...
Veradigm Launches Health Network Architecture to Level the Playing Field for Independent Practices
CHICAGO--(BUSINESS WIRE)--Veradigm® (OTCMKTS: MDRX), a leading provider of clinical and revenue cycle solutions for independent practices, today announced the availability of the Veradigm Health Netwo...
Veradigm Survey: Independent Practices Rely on Technology to Stay Independent
CHICAGO--(BUSINESS WIRE)--Veradigm® (OTCMKTS: MDRX), a leading provider of clinical and revenue cycle solutions for independent practices, today released findings from a nationally distributed survey ...
Veradigm Receives KLAS 2026 Points of Light Award for Embedding SDOH Data in Provider EHR Workflows
CHICAGO--(BUSINESS WIRE)--Veradigm® (OTCMKTS: MDRX), a leading provider of clinical and revenue cycle solutions for independent practices, today announced that it has been recognized by KLAS in the 20...
Veradigm Doubles India-Based Employee Footprint, Adds New Managing Director
PUNE, India--(BUSINESS WIRE)--Veradigm® India Private Limited, the India subsidiary of Veradigm (OTCMKTS: MDRX), a US-based leader in clinical and revenue cycle solutions for independent practices, to...
Veradigm names Christian Greyenbuhl CFO
Veradigm (MDRX) announced the appointment of Christian Greyenbuhl as Chief Financial Officer of the company, effective on the later of May 11, 2026 and the first business day after Veradigm…
Veradigm Appoints Christian Greyenbuhl as Chief Financial Officer
CHICAGO--(BUSINESS WIRE)--Veradigm Inc. (OTCMKTS: MDRX), a leading provider of clinical and revenue cycle solutions for independent practices, announced the appointment of Christian Greyenbuhl as Chie...
Veradigm Transcript: Status update
Reset, Recover, Reignite plan is underway, with discontinued low-revenue products and capital reallocated to growth bets. 2025 revenue was flat, but operational and AI-driven initiatives are expected to drive growth and profitability in 2026. SEC filing progress continues, with the Super K as the next milestone.
Veradigm Press release: Status update
Veradigm issued a press release on February 18, 2026, disclosing material business information to investors.
Veradigm Provides Business and Strategy Update
CHICAGO--(BUSINESS WIRE)--Veradigm® (OTCMKTS: MDRX), a leading provider of clinical and revenue cycle solutions for independent practices, is providing estimated financial performance for the fiscal y...
Veradigm Brings Patient Voice to Healthcare Research with New Real-World Data Survey Solution
CHICAGO--(BUSINESS WIRE)--Veradigm (OTCMKTS:MDRX), a leading provider of clinical and revenue cycle solutions for independent practices, today announced a new patient‑reported outcomes (PRO) survey ca...
Veradigm to Release Business Update February 17th and Host Investor Call February 18th
CHICAGO--(BUSINESS WIRE)--Veradigm® (OTCMKTS: MDRX), a leading provider of clinical and revenue cycle solutions for independent practices, announced today that management plans to provide a business u...
Veradigm Extends Stockholder Rights Plan
CHICAGO--(BUSINESS WIRE)--Veradigm® (OTCMKTS: MDRX), a leading provider of clinical and revenue cycle solutions for independent practices, today announced that its Board of Directors (the “Board”) has...
Veradigm launches new AI application Veradigm Revenue Cycle Services
Veradigm (MDRX) announced the launch of a new AI-enabled application for Veradigm Revenue Cycle Services clients, designed to deliver faster, deeper revenue cycle insights and strengthen the value of ...
Veradigm Launches New AI Application for Powerful Revenue Cycle Insights for Independent Practices
CHICAGO--(BUSINESS WIRE)--Veradigm® (OTCMKTS: MDRX), a leading provider of clinical and revenue cycle solutions for independent practices, today announced the launch of a new AI-enabled application fo...
Veradigm and Meperia Launch Industry-First 8-Way Match EDI Platform to Strengthen Healthcare Supply Chain Integrity
CHICAGO & VERO BEACH, Fla.--(BUSINESS WIRE)--Veradigm® (OTCMKTS: MDRX), a leading provider of healthcare data, technology, and enterprise resource planning (ERP) solutions, and Meperia (now part of Ge...
Veradigm Launches Enhanced Ambient Scribe Capabilities
CHICAGO--(BUSINESS WIRE)--Veradigm® (OTCMKTS: MDRX), a leading provider of healthcare data and technology solutions, today announced enhancements to the artificial intelligence (AI) enhanced Ambient S...
Veradigm Adds Sentara Health Plans to Veradigm Payer Insights Solution
CHICAGO--(BUSINESS WIRE)--Veradigm® (OTCMKTS: MDRX), a leading provider of healthcare data and technology solutions, announced today a new agreement with Sentara Health Plans, a prominent regional hea...
Veradigm Appoints Tehsin Syed as Chief Product and Technology Officer
CHICAGO--(BUSINESS WIRE)--Veradigm® (OTCMKTS: MDRX), a leading provider of healthcare data and technology solutions, today appoints Tehsin Syed, a healthcare technology leader with over two decades of...
Veradigm Transcript: Investor Update
Revenue remains stable with strong recurring streams and a net cash positive position. Strategic priorities include improving profitability, reigniting growth, and achieving SEC filing compliance, with relisting targeted for 2026. Leadership emphasizes operational discipline and leveraging data assets.
Veradigm Press release: Investor Update
Veradigm issued a press release on October 1, 2025, disclosing material business information to investors.
Veradigm Provides 2025 Business Update
CHICAGO--(BUSINESS WIRE)--Veradigm® (OTCMKTS: MDRX), a leading provider of healthcare data and technology solutions, is providing estimated financial performance for the second quarter of 2025 compare...